- Home
- JVSA vs PDSB Comparison
JVSA vs PDSB Comparison
Compare JVSA & PDSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JVSA
- PDSB
- Stock Information
- Founded
- JVSA 2021
- PDSB 2005
- Country
- JVSA Hong Kong
- PDSB United States
- Employees
- JVSA N/A
- PDSB N/A
- Industry
- JVSA
- PDSB Biotechnology: Pharmaceutical Preparations
- Sector
- JVSA
- PDSB Health Care
- Exchange
- JVSA NYSE
- PDSB Nasdaq
- Market Cap
- JVSA 82.7M
- PDSB 72.2M
- IPO Year
- JVSA 2024
- PDSB N/A
- Fundamental
- Price
- JVSA $10.85
- PDSB $1.75
- Analyst Decision
- JVSA
- PDSB Strong Buy
- Analyst Count
- JVSA 0
- PDSB 2
- Target Price
- JVSA N/A
- PDSB $10.00
- AVG Volume (30 Days)
- JVSA 68.6K
- PDSB 892.6K
- Earning Date
- JVSA 01-01-0001
- PDSB 05-14-2025
- Dividend Yield
- JVSA N/A
- PDSB N/A
- EPS Growth
- JVSA 719.53
- PDSB N/A
- EPS
- JVSA 0.27
- PDSB N/A
- Revenue
- JVSA N/A
- PDSB N/A
- Revenue This Year
- JVSA N/A
- PDSB N/A
- Revenue Next Year
- JVSA N/A
- PDSB N/A
- P/E Ratio
- JVSA $39.96
- PDSB N/A
- Revenue Growth
- JVSA N/A
- PDSB N/A
- 52 Week Low
- JVSA $10.13
- PDSB $0.85
- 52 Week High
- JVSA $11.91
- PDSB $4.42
- Technical
- Relative Strength Index (RSI)
- JVSA N/A
- PDSB 65.84
- Support Level
- JVSA N/A
- PDSB $1.38
- Resistance Level
- JVSA N/A
- PDSB $1.76
- Average True Range (ATR)
- JVSA 0.00
- PDSB 0.13
- MACD
- JVSA 0.00
- PDSB 0.02
- Stochastic Oscillator
- JVSA 0.00
- PDSB 77.78
About JVSA JVSPAC ACQUISITION CORP
JVSPAC Acquisition Corp is blank check company.
About PDSB PDS Biotechnology Corporation
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.